Jump to Main Content

Meetings

ASH Consultative Hematology Course

September 9, 2021
Virtual

The ASH Consultative Hematology Course (CHC) is a virtual half-day program led by faculty familiar with consultative practice issues and commonly encountered clinical problems that require the expertise of a hematologist. Program participants engage in case-based presentations and have the opportunity to interact with experts during the live Q&A panel. The 2021 program features discussions on non-malignant hematology topics, such as inherited bone marrow disorders, sickle cell disease, microangiopathies, and rare bleeding disorders.

Register now

Join the meeting

Program Co-Chairs

  • Jeffrey M. Lipton, MD, PhD, Northwell Health
  • Anaadriana Zakarija, MD, Northwestern University

Program Schedule

The following program corresponds to the 2021 Consultative Hematology Course. All sessions listed are in Central time.

Thursday, September 9

Time  Session Speakers
2:00 p.m. Welcome and Opening Remarks

Jeffrey M. Lipton, MD, PhD, Northwell Health

Anaadriana Zakarija, MD, Northwestern University

2:10 p.m. Inherited Bone Marrow Disorders Jeffrey M. Lipton, MD, PhD, Northwell Health
2:35 p.m.
Diagnosis of Rare Bleeding Disorders Suchitra Acharya, MD, MBBS, Northwell Health
3:00 p.m.
New Sickle Cell Disease Therapies and Transitions to Adult Care Julie Kanter, MD, University of Alabama at Birmingham
3:20 p.m.

Program Break

 
3:35 p.m.
Hemophagocytic Lymphohistiocytosis (HLH) Ashish Kumar, MD, PhD, Cincinnati Children’s Hospital
4:00 p.m.
DOAC Reversal and Heavy Menstrual Bleeding Anaadriana Zakarija, MD, Northwestern University
4:25 p.m.
Antiphospholipid Antibody Syndromes (APS) Thomas L. Ortel, MD, PhD, Duke University
4:45 p.m. Program Break  
5:00 p.m.  Live Q&A Panel with All Speakers & Closing Remarks

Jeffrey M. Lipton, MD, PhD, Northwell Health

Anaadriana Zakarija, MD, Northwestern University

Suchitra Acharya, MD, MBBS, Northwell Health

Julie Kanter, MD, University of Alabama at Birmingham

Ashish Kumar, MD, PhD, Cincinnati Children’s Hospital

Thomas L. Ortel, MD, PhD, Duke University

*Session topics and speakers are subject to change and speakers will be updated upon final approval by the American Society of Hematology.

Related Content